Notably, two LUAD-BM (15.4%) and three LUSC-BM (11.1%) samples contained pathogenic alterations in CDK12, further implicating this potentially targetable gene in the pathogenesis of NSCLC-BM. Here, CDK12 is linked to non-small cell lung carcinoma.